Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Guo, Chunguang, Li, Jing, Xu, Hui, Lu, Taoyuan, Wang, Libo, Liu, Long, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684773/
https://www.ncbi.nlm.nih.gov/pubmed/34923755
http://dx.doi.org/10.1002/ctm2.619
_version_ 1784617689316065280
author Liu, Zaoqu
Guo, Chunguang
Li, Jing
Xu, Hui
Lu, Taoyuan
Wang, Libo
Liu, Long
Han, Xinwei
author_facet Liu, Zaoqu
Guo, Chunguang
Li, Jing
Xu, Hui
Lu, Taoyuan
Wang, Libo
Liu, Long
Han, Xinwei
author_sort Liu, Zaoqu
collection PubMed
description
format Online
Article
Text
id pubmed-8684773
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86847732021-12-30 Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types Liu, Zaoqu Guo, Chunguang Li, Jing Xu, Hui Lu, Taoyuan Wang, Libo Liu, Long Han, Xinwei Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-12-19 /pmc/articles/PMC8684773/ /pubmed/34923755 http://dx.doi.org/10.1002/ctm2.619 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Liu, Zaoqu
Guo, Chunguang
Li, Jing
Xu, Hui
Lu, Taoyuan
Wang, Libo
Liu, Long
Han, Xinwei
Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title_full Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title_fullStr Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title_full_unstemmed Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title_short Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
title_sort somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684773/
https://www.ncbi.nlm.nih.gov/pubmed/34923755
http://dx.doi.org/10.1002/ctm2.619
work_keys_str_mv AT liuzaoqu somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT guochunguang somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT lijing somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT xuhui somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT lutaoyuan somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT wanglibo somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT liulong somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes
AT hanxinwei somaticmutationsinhomologousrecombinationpathwaypredictfavourableprognosisafterimmunotherapyacrossmultiplecancertypes

Ejemplares similares